Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 18 dec 2007 - 10:01
- Statutory name Crucell N.V.
- Title DSM Biologics and Crucell Announce PER.C6® Licensing Agreement with Medarex Inc.
- Comments Sittard/Leiden, The Netherlands, December 18, 2007 – DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced a PER.C6® license agreement with biopharmaceutical company Medarex, Inc. This license agreement allows Medarex to use the PER.C6® production platform in its antibody research. Financial details of the agreement were not disclosed.
Date last update: 31 March 2020